GB2168053A - Phenexy-phenyl oxirane compounds - Google Patents
Phenexy-phenyl oxirane compounds Download PDFInfo
- Publication number
- GB2168053A GB2168053A GB08530463A GB8530463A GB2168053A GB 2168053 A GB2168053 A GB 2168053A GB 08530463 A GB08530463 A GB 08530463A GB 8530463 A GB8530463 A GB 8530463A GB 2168053 A GB2168053 A GB 2168053A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- hydrogen
- formula
- phenyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Polymerization Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Oxirane derivatives of the formula II <IMAGE> wherein R1 and R2 are each independently hydrogen, halogen, C1-C4alkyl or CF3, and Rn denotes one to three alkyl, alkoxy, haloalkoxy, haloalkyl, halogen and/or cyano groups, R4 is hydrogen, C1-C10alkyl, C3-C6cycloalkyl or unsubstituted or substituted phenyl; and A is the radical <IMAGE> wherein R6 and R7 are each independently C1-C12alkyl, unsubstituted or substituted phenyl, or both together form a C2-C4-alkylene bridge which is unsubstituted or substituted by one or more identical or different members selected from the group consisting of C1-C4alkyl, C2-C4alkenyloxymethyl or C1-C3alkoxymethyl, are useful for preparing microbicidal 1-phenoxyphenyl-2-azolylethanol compounds.
Description
1
GB 2 168 053 A 1
SPECIFICATION
Oxirane compounds
5 The present invention relates to novel oxirane compounds, their preparation and use. g
Accordingly, the invention relates to compounds of the general formula II
Yx*2 o
" x : n A
10 • - 0 -4- -H c—CH (II) 10
X / \ ' I
Rn.=. \/ A
R4
15 15
wherein
Rt and R2 are each independently hydrogen, halogen CrC4 alkyl or CF3, and Rn denotes one to three alkyl,
alkoxy, haloalkoxy, haloalkyl, halogen and/or cyano groups,
R4 is hydrogen, CrC10alkyl, C3-C6cycloalkyl or unsubstituted or substituted phenyl, and 20 A is the radical 20
I
-C-OR7
I /
25 0Re' 25
wherein
30 Reand R7 are each independently CrC12alkyl, unsubstituted or substituted phenyl, or both together form a 30 C2-C4alkylene bridge which is unsubstituted or substituted by one or more identical or different members selected from the group consisting of Ci-C4alkyl, C2-C4alkenyloxymethyl or Ci-C3alkoxymethyl.
Depending on the indicated number of carbon atoms, alkyl by itself or as moiety of another substituent comprises e.g. the following groups: methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl 35 etc., and their isomers, e.g. isopropyl, isobutyl, tert-butyl, isopentyl etc. 35
Throughout this specification, halogen denotes fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine. Alkenyl is is e.g. propen-l-yl, allyl, buten-1-yl, buten-2-yl or buten-3-yl. Depending on the number of carbon atoms, cycloalkyl denotes e.g. cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl,
cycloheptyl, cyclooctyl etc. Possible substituents of unsubstituted or substituted phenyl, phenoxy or benzyl, 40 regardless of the position of the phenyl, phenoxy or benzyl in the molecule, are C-|-C4alkyl, C-|-C4alkoxy, 40
CrCahaloalkyl, halogen and/or cyano. Haloalkyl denotes here a mono-to perhalogenated alkyl substituent, e.g. CHCI2, CHF2, CH2CI, CCI3, CH2F, CH2CH2CI, CHBr2 and preferably CF3.
Where R6and R7 in the molecular fragment
45
-C-OR7
| 1
OR£'
45
50 50
together form a C2-C4alkylene bridge, said fragment, depending on the number of carbon atoms, is an unsubstituted or substituted 1,3-dioxolan, 1,3-dioxan or 1,3-dioxepane ring.
The oxirane compounds of the present invention are useful for preparing microbicidal 1-phenoxyphenyl-2-55 azolylethanol compounds as described and claimed in copending application No. 8330970 (Serial No. 55
2130584). On account of the pronounced microbicidal action of the corresponding 1-phenoxyphenyl-2-azolylethanol compounds, preferred compounds of the formula II in increasing order of preference, are those compounds which contain the following substituents or combinations thereof:
For Rt and R2, each independently of the other:
60 a) hydrogen, halogen, CrC3alkyl, CF3; 60
b)H,F,CI,Br,CH3,C2H5,CF3.
c) R1: H, 2-CI, 2-Br, 2-F, 2-CF3,3-F, 3-CI, 3-Br, 3-CF3,4-CI, 4-Br, 4-F, 4-CF3, 5-CI, 5-Br, 5-F, 5-CF3.
R2: H.
d) R-i: 2-H, 2-F, 2-CI, 2-Br, 2-CH3.
65 R2: H. 65
2
GB 2 168 053 A
2
For Rn:
a) Cn-C4alkyl, CrC4alkoxy, CrC4haloalkoxy, Ci-C3haloalkyl, halogen and/or cyano;
b) chlorine, dichloro, fluorine, bromine, methyl, difluoro, CF3, OCF3;
c) 4-chloro, 2,4-dichloro, 4-fluoro, 2,4-difluoro, 4-bromo, 4-methyl, 4-CF3,4-OCF3;
5 d) All meanings as under c), except that for the p-phenoxyphenyl group: 5
I I
For A: a) -C-0(CrC4alkyl), -C-0(CrC4alkyl),
I I
10 0(CrC4alkyl) Ofunsubstituted or substituted phenyl) 10
-c- -c- -c-
/\ /\ /\ 0 0 0 0 0 0
15 11 1 I II 15
1b •—• > *—alkyl, C^-C^alkyl-*—•-Cj-C^.alkyl,
-C- -C- -o
/\ A A
0 0 0 0 0 0
,n 1 I I I' II 20
• •—CH^OCH^ , • •-CH20CH2CH=CH2 , . • ,
-c- -C- -c-
/\ A A
oc 0 0 0 0 0 0 oc
25 I I II II 25
• • I • • • •
\/\ \/ ■ /\/\ '
• Cj-C^alkyl Cj-C^-alkyl • C^-alkyl
30 ^"^alkyl Cj-C^alkyl 3Q
-C- -C-
/\ . /\
0 0 0 0
1 i ii
35 • •-C,-C. alkyl • • 35
\/ 1 4 \/
• •
/\ \
Cj^-C^alkyl C,-Chalky1 C^-C^alkyl ,
40 | [ 40
b) -C-OCH3 -C-OC2,H5 ^C- -C-
0CH3 0C2Hs
0 0 0 0
•—• , •—•-C.-C,alkyl ,
45 13-' 45
-c- -c- -c- • -c-
/\ /\ /\ /\
00 00 0000
II II I I I I
• —CH.0CH, , CH,—• »-CH,
50 2 3 3 \/ \/\ 50
• • CHj
-C- -C- -C-
/\ /\ /\
0 0 0 0 0 0
55 I I I I I I 55
• « . •• • * «
/\/\ \/ \/
CH3 • CH„
/\
CH, CH_ CH.
60 3 3 3 60
For R4:
a) hydrogen, CrC6alkyl, C3-C6cycloalkyl, phenyl, or phenyl substituted by C1-C4alkyl, CrC4alkoxy, CrC4haloalkyl, halogen or cyano;
b) hydrogen, CrC4alkyl, C3-C6cycloalkyl, phenyl or phenyl substituted by methyl, methoxy, CF3, F, CI, Br or
65 CN; 65
3
gb 2 168 053 a
3
c) hydrogen, methyl, phenyl, 2,4-dichlorophenyl;
d) hydrogen.
• Accordingly, the following groups of compounds for example are preferred in increasing order of preference:
5 a) compounds of the formula II, wherein R-i and R2 are each independently hydrogen, halogen, C-i-Csalkyl 5 or CF3; Rn is CrC4alkyl, C-|-C4alkoxy, CVC^haloalkoxy, CrC3haloalkyl, halogen and/or cyano; A is one of the molecular fragments
10 -C-0(Ci-C4alkyI)( -C-0(C1-C4alkyl), 10
I I
0(Cn-C4alkyl) Ofunsubstituted or substituted phenyl)
15 A A A 15
0000 oo-
1 I II. II
• —• , •—•-C^-C^alkyl, Cj-C^alkyl-"—•-C^-C^alkyX,
20 A A A 20
0 0 0 0 ' 0 0
> •-CH2OCH3 , • •-CH^CH, CH=CH2
\/
25 * 25
-c- -c- - -c-
/\ /\ A
0 0 0 0 0 0
II II II
30 \ /\ ' \ / ' A A . 30
• C^-C^alkyl • Cj-C^-alkyl • C^-C^-alkyl
C^-C^alkyl C^-C^alkyl
-C- -C-
35 / \ A 35
0 0 0 0
II II
• •-C.-C.alkyl Or • •
\/ 1 4 \/
• •
40 A \ 40
C^-C^alkyl C^C^alkyl Cj-^alkyl , ;and
R4 is hydrogen, CrCealkyl, C3-C6cycloalkyl, phenyl or phenyl substitued by CrC4aikyl, CrC4alkoxy,
CrC3haloaikyl, halogen or cyano.
45 b) compounds of the formula a II, wherein each of Rn and R2are independently hydrogen, fluorine, 45
chlorine, bromine, methyl, ethyl or CF3; Rn is hydrogen, chlorine, dichloro, fluorine, bromine, methyl,
difluoro, CF3 or OCF3; A is one of the molecular fragments j | -c- -c-
-c-och3 -c-oc2h5 A A
I I oooo och3 oc2h5
•— -Cj-Cjalkyl ,
-c-
/\ 0 0
-c-
/\ 0 0"
-c-
A
0 0
-c-
/\ 0 0
-•-CH20CH3
CH3-»—*-CH3
\/
\/\
CH-
4 GB 2 168 053 A
4
-c- -c-
/\ /\
0 0 0 0
II II
• • or • • ;and
5 \/ \/ 5
• •
I /\
ch3 chj ch3
10 R4 is hydrogen, CrC4alkyl, C3-C6cycloalkyl, phenyl or phenyl substituted by methyl, methoxy, CF3, F, CI, Br or 10 CN.
c) compounds of the formula II, wherein R1 is hydrogen, 2-CI, 2-Br, 2-F, 2-CF3,3-F, 3-CI, 3-Br, 3-CF3,2-CH3, 4-CI, 4-Br, 4-F, 4-CF3,5-CI, 5-Br, 5-F or 5-CF3; R2 is hydrogen; Rn is 4-chloro, 2,4-dichloro, 4-fluro, 2,4-difluoro, 4-bromo, 4-methyl, 4-CF3 or 4-OCF3; A is one of the molecular fragments 15 15
[ | -g- -c-
-c-och3 -c-oc2h5 / \ / \
1 I oooo
I ' 1 'II II
och3 oc2h5 l_i . i_i_c c lkyl ,
20 1 3 20
-c- -c- -c- -c-
/\ /\ /\ /\ 00 00 oooo
II II I I I I
25 * CH2OCH3 1 CH3-° CH3 ' \/ ' \/\ ' 25
• • ch.
30 _c_ -c- -c- 30
/\ /\ /\
00 00 00
11 11 11
. • • • or • • ; and
35 /X/X X/ X/ ' 35
1,5 ch3 • ch3 • • d5>
ch3 ch3 ch3
40 R4 is hydrogen, methyl, phenyl or 2,4-dichlorophenyl. 40
d) compounds of the formula II, wherein R-i is 2-H, 2-F, 2-CI, 2-Br or 2-CH3; R2is hydrogen; Rn in a para-positioned phenyl group is 4-chloro, 2,4-dichloro, 4-fluoro, 2,4-difluoro, 4-bromo, 4-methyl, 4-CF3 or 4-OCF3; A is one of the molecular fragments
1 1 ?C\ "A
-C-OCHg -C-OC2H5 . / \ / \
I I 00 00
och3
oc2h5
• —
• •
—*"Cl~C3alkyl
-c-
/\
0 0
1 |
-c-
/\
0 0
1 1
-c-
/\
0 0
1 1
-c-
/\
0 0
1 1
1 i
• —CUyOCK^
, ch3-
1 1 -.——ch3
l l
' \/ •
1 1 • •
\/\ • ch3
-c-
/\
0 0
1 1
-c-
/\
0 0
1 i
-g-
/\
0 0
1 |
i 1 • •
/\/\ a3 • cil3
1 1
• \/ •
1
ch3
or i 1 • •
\/
•
/\
ch3 ch3
. ; and
5
GB 2 168 053 A 5
R4is hydrogen.
The oxiranes of formula II are novel and constitute specially developed intermediates for the preparation of the valuable 1-phenoxyphenyl-2-azolylethanol compounds described in copending application No.
8330970. Their structural nature makes it possible for them to be converted in simple manner into those 5 compounds. 5
Further, some of the compounds of formula II arefungicidally active against harmful fungi of thefamilies Ascomycetes, Basidiomycetes or Fungi imperfecti.
The oxiranes of the formula II can be prepared in a manner known perse by epoxidation of the corresponding styrene derivatives of the formula VI
10 — Yx*2 10
// w x /"°1; i—r* ,w'
is V f
R4
wherein Rt to R4are as defined for formula II, for example by oxidation with peracids such as peracetic acid, tert-butylhydroperoxide, m-chloroperbenzoic acid, H202 and the like, and optionally in the presence of a 20 base such as NaOH, KOH, NaHC03, in conventional inert solvents. Mo(CO)6 can be used as catalyst in this 20 reaction.
The styrene derivatives of the formula VI can be prepared as described in Org. Synth. 60,6, from the known styrenes of the formula VIII
25 Y/2 25
// \
• - 0 -+ -H CH=CH, (VIII),
v=* \/
30 30
wheren Rt to R3 are as defined for formula I, by reaction with dichlorocarbene (CHCI3/NaOH) and subsequent alcoholysis with alcohols of the formula R6OH, R7OH and/or HO-R6R7-OH.
Epoxides of the formula II, wherein the molecular fragment A is the group
35 | 35
-C-OR7
I '
OR£'
40 40
can be prepared in a manner known perse from ketones of the formula IX
R, • R„ R
45
'm
40R
7, 45
^ * • / (,X)
• • - o -4- -P c—c ' llX)
X / • / II \ ■
r •=• \ / 0 OR,
n # 6
50 by reaction with dimethylsulfonium methyl imide or dimethyloxo-sulfonium methyl imide (Corey and 50
Chaykovsky, J ACS, 1962,84,3782).
The ketones of formula IX are obtainable by different methods which are known from the literature, e.g.
where R4 is hydrogen, e.g. by reacting known substituted acetophenones with the corresponding known alcohols R6-OH or R7-OH, in the presence of nitrosyl chloride, or with the alkyl nitrites ReO-NO or R70-N0 55 (q-v. DE-OS 2 730 462 and DE-OS 2 432 563). 55
Further, substituted phenylglyoxals can also be converted selectively into the acetals of the formula IX.
Acetals or ketones of the formula IX, wherein e.g. R4 is hydrogen and R6and R7 are alkyl, can also be prepared from a-halo-a-acetoxyacetophenone by reaction with alcohols [W. Madelung and M.E. Oberweg-ner, Chem. Ber. 65,931 (1932)].
60 Unless otherwise expressly specified, one or more inert solvents or diluents may be present in the 60
preparation of all starting materials, intermediates and final products mentioned herein. Examples of suitable inert solvents or diluents are: aliphatic and aromatic hydrocarbons such as benzene, toluene,
xylenes, petroleum ether; halogenated hydrocarbons such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride, tetrachloroethylene; ethers and ethereal compounds such as 65 dialkyl ethers (diethyl ether, diisopropyl ether, tert-butylmethyl ether etc.), anisole, dioxane, tetrahydrofur- 65
6
GB 2168053 A
6
ane; nitriles such as acetonitrile, propionitrile; N,N-dialkylated amides such as dimethyl formamide; dimethylsulfoxide; ketones such as acetone, diethyl ketone, methyl ethyl ketone; and mixtures of such solvents with each other. It can often be convenient to carry out the reaction, or partial steps of a reaction,
under an inert gas atmosphere and/or in absolute solvents. Suitable inert gases are nitrogen, helium, argon 5 or, in certain cases, also carbon dioxide. 5
The above described preparatory process, including all partial steps, constitutes an important object of the present invention.
The invention is illustrated in more detail by the following Examples, without implying any restriction to what is described therein. Parts and percentages are by weight.
10 10
Preparatory examples Example PI:
a) Preparation of the intermediate
OCH-
15 / \ / \ / 3 15
Cl-« •-0-* •-C-CH.
\ / \ / I! \
•=• •=• 0 0CH3
20 4-(4-Chlorophenoxy)phenylglyoxal dimethyl acetal 20
158g of a-acetoxy-a-bromo-4-(4-chlorophenoxy)acetophenone in 800 ml of absolute methanol are heated to 60°Cfor 1 hour. After half of the methanol has been distilled off, the solution is poured into water and extracted with diethyl ether. The combined extracts are dried over sodium sulfate, filtered, and concentrated in vacuo. The residue is recrystallised from diisopropyl ether. Yield: 61 g of yellowish crystals with a melting
25 point of 63°-64°C. 25
b) Preparation of the final product
30
OCH,
!/ \ H \ / 3
Cl-« •-()-• •—C CH
\ \
0GH3
\ / \ /
30
o
2-[4-(4-Ch/orophenoxyphenylJ-2-dimethoxymethy/oxirane 35 To a dispersion of 80% sodium hydride in 400 ml of absolute dimethyl sulfoxide are added 47.9 g of 35
trimethyloxosulfonium iodide in portions under nitrogen. After the exothermic reaction has subsided, the mixture is stirred for 90 minutes and then a solution of 55 g of 4-)4-chlorophenoxy)phenylglyoxal dimethyl acetal in 150 ml of tetrahydrofuran is added dropwise at normal temperature. The mixture is heated to 60°c and stirred for 1 hour. Then the reaction mixture is poured into ice/water and extracted repeatedly with 40 diethyl ether. The combined extracts are washed with brine and water, dried over sodium sulfate, filtered, 40 and concentrated in vacuo, affording 59 g of a brown oil which can be either purified by column chromatography or further processed as crude product.
The following final products can be prepared in corresponding manner;
7
GB 2 168 053 A 7
10
obtained as viscous oils or resins.
Compound
R1
R2
R
A
R4
4.1
H
H
4"0C,H.C1(4) 6 4
-C-
CH30/ X0CH3
H
4.2
H
H
4-OC.H,Cl(4) 6 4
H
4.3
H
H
4-OC6H4F(4)
H5C2O' nOC2H5
H
4.4
CI (2)
H
4-OC,H.Cl(4) 6 4
;c\
H^CO OCH3
H
4.5
H
H
4-OCgH4Cl(4)
? ? —LC2H5
H
4.6
H
H
4-OC6H4Br(4)
CH30 OCH3
H
4.7
H
H
4-OCgH4Br(4)
-c-
??
C2H5
H
4.8
CH3(2)
H
4-0C,H.Cl(4)
b 4
-c-
ch3ooch3
H
TABLE 4 Compounds of the formula
I1
X / \ 2
B. t"
R2 t
*4
10
8 GB 2 168 053 A
8
TABLE 4 (continuation)
Compound
R1
R2
r a
R4
4.9
CH3(2)
H
4-0C,H,CI(4)
b *+
A
H
4.10
CH3(2)
H
4-0C,H Br(4)
0 4
-C-
CH30X N0CH3
H
4.11
CH3(2)
H
4-OC6H4Cl(4)
-c-
H5C2Q/ 0C2H5
h
4.12
H
h
4-OC6H4Cl(4)
-c-CH30X 0CH3
ch3
4.13
h
H
4-OCgH4Br(4)
7c\
H5C2O/ nOC2H5
ch3
4.14
CH3(2)
H
4-0C6H4ClC4)
-c-
H5C2O/ nOC2H5
ch3
4.15
CH3(2)
H
4-OC H.Cl(4) 6 4
-c-
< ?
c2h5
4.16
CH3(2)
H
4-0C,H.Br(4) 6 4
-c-
CH30/ 0CH3
c2Hs
GB 2 168 053 A 9
TABLE 4 (continuation)
Compound
R1
R2
R
A
4.17
CH3(2)
H
4-OC.H,F(4)
6 4
?A?
2 5
C3H7-n
4.18
CH3(2)
H
4-OC6H4Cl(4)
n-H
^C30 OC3H7~U
C(CH3)3
4. 19
CH3(2)
H
4-OCgH^Br(4)
7C\ ch3o noch3
C3H7-i
4.20
CH3(2)
H
4-OC5H4Cl(4)
O—•
i/ \
•v./
ch3
4.21
Cl(2)
H
4-OC5H4Cl(4)
CH3(/C~0CH3
H
4.22
H
H
4-OC,H.Cl(4) 6 4
—C—
H5C20/ 0C2H5
H
4.23
H
H
4-OC H CI(4) 6 4
h5c2o oc2h5
H
4.24
H
H
4-OC6H3Cl2(2,
4)
A
1—l-c2s5
H
10 GB 2 168 053 A
TABLE 4 (continuation)
Compound
*1
*2
R
A
R4
4.25
H
H
4-OC6H4Cl(4)
?A?
• l-ch2och3
H
4.26
CH3(2)
H
4-0C H.C1(4) 6 4
/s
• l-ch20ch3
H
4.27
CH3(2)
H
4-OCgH^CX(4)
.3C-A-CH,
H
4.28
CI (2)
H
4-OC HCI(4) 6 4
"3C"—---C".
H
4.29
H
H
4-OCgH^Cl(4)
A
H
\ /T
CH3
4.30
CH3(2)
H
4-OC6H4Cl(4)
A
H
x-/ nch3
4.3 1
CI (2)
h
4-OC6H4Cl(4)
nAn ? ?
V\H3
H
GB 2 168 053 A 11
TABLE 4 (continuation)
Cora-
R1
r2
r
A
R4
pound
1
4.32
Cl(2)
H
4-OC H CI (2,4) 6 J *•
?/C\
—i-C2H5
H
4.33
CH3(2)
H
4-0CgH4Cl(4)
/S
~C2H5
H
4.34
CH3(2)
H
4-0C,H.Cl(4)
o 4
?A?
3 7*11
H
4.35
CH3(2)
H
4-OC6H4Cl(4)
?A?
! LC2H5
H
4. 36
CH3(2)
H
4-OCgH4Cl(4)
?A?
CH3
v\*3
4. 37
CI (2)
H
4-OC.H Cl(4) b 4
i—J-ch2och3
CH3
4. 38
CH3(2)
H
3-OC,H,Cl(4) o 4
-c-
cn^ nOCH3
H
4. 39
CH3(4)
H
3-OC6H4Cl(4)
;c"
CH30 0CH3
H
4.4°
CI (2)
h
3-OC6H4Cl(4)
A « *
H
12
GB 2 168 053 A
12
TABLE 4 (continuation)
5
Compound
R1
R2
R
A
R4
5
10
4.4 1
CH3(2)
H
3-0C,H.CH,(4)
/S
i c2h5
H
10
4.42
CH3(2)
H
3-OC,H,Cl(4) 6 4
~-CA
H
15
15
20
20
25
4.43
CI (2)
H
3-0C H,CI(4) 6 4
A
V\H3
H
25
30
4.44
CH3(2)
H
3-OC6H4Cl(4)
A • •
\ / \ IT
CH3
H
30
4.45
CH (2) 3
H
3-OC H.CI(4) 6 b-
?/G>
• i-CH20CH3
H
35
35
4.46
CI (2)
H
3-OC,H,Cl(4) 6 4
?A?
• 1-CH20CH3
H
40
40
Claims (1)
- 45 CLAIMS1. A compound of the formula II50Yx*2 o• • - 0 —|- 4 G —CH-x ' \r 1R •=• \ / A55\(IDwhereinRt and R2 are each independently hydrogen, halogen CT^alkyl or CF2, and Rn denotes one to three alkyl, alkoxy, haloalkoxy, haloalkyl, halogen and/or cyano groups,R4 is hydrogen, C1-C10alkyl, C3-C6cycloalkyl or unsubstituted or substituted phenyl, and 60 A is the radical45505560-C-OR7a*;13GB 2 168 053 A13whereinR6 and R7 are each independently CrC12alkyl, unsubstituted or substituted phenyl, or both together form a C2-C4alkylene bridge which is unsubstituted or substituted by one or more identical or different members selected from the group consisting of CrC4alkyl, C2-C4alkenyloxymethyl or CrCsalkoxymethyl. 5 2. a compound ofthe formula II according to claim 1, wherein Rt and R2 are each independently 5hydrogen, halogen, Ci-C3alkyl or CF3; Rn is CrC4alkyl, Ci-C4alkoxy, CrC4haloalkoxy, Cn-C3haloalkyl, halogen and/or cyano; A is one of the molecularfragments10 -C-0(CrC4alkyl), -C-0(CrC4alkyl), 10I I0(CrC4alkyl) Ofunsubstituted or substituted phenyl)-c- -c- -c-15 /\ /\ /\0000 001 I I I II• —• . , • — •-C^-C^alkyl, Cj-C^alkyl-* — •-C^-C^alkyl,-C- -C- -C-20 / \ / \ / \0 0 0 0 0 0• •-CH20CH3 , • •-CH20CH2CH=CH2\/0 0 0 0och3 oc2h5, •—•-C^-C^alkyl ,-C- -c- -C- -C-/\ /\ /\ /\ 00 00 oooo-CH2OCH3 , CH3~«—«-CH3\/ \/\ • • CH,152025 A A A 2500 0 0 0 0II II II• • I • • I • •\/\ \/ /\/\ 30 • Cj-C^alkyl • C^C^alkyl • C^C^-alkyl 30C^-C^alkyl C^-C^alkyl-c- -C-35 / \ . / \ 3500 00II II* -C, alkyl or • •\/ \/• .40 r r ,, {\ 0 ,, , \ 40CrC4alkyl C1-C4alkyl C1-C4alkyl ; andR4 is hydrogen, Cn-C6alkyl, C3-C6cycloalkyl, phenyl or phenyl substitued by CrC4alkyl, CrC4alkoxy,CrCshaloalkyl, halogen or cyano.45 3. Acompound of the formula II according to claim 1 wherein each of the R-i and R2 independently 45hydrogen, fluorine, chlorine, bromine, methyl, ethyl or CF3; Rn is chlorine, dichloro, fluorine, bromine,methyl, difluoro, CF3 or OCF3; A is one of the molecularfragmentsII -c- -c--C-0CH3 -C-OC2H5 / \ A14 GB 2 168 053 A14-c-/\-c-/\0 01 10 01 11 1 • •1or , .\/\/IAgh3ch3 ch.10 R4 is hydrogen, Ci-C4alkyl, C3-C6cycloalkyl, phenyl or phenyl substituted by methyl, methoxy, CF3, F, CI, Br or 10 CN.4. A compound of the formula II according to claim 3, wherein R-i is hydrogen, 2-CI, 2-Br, 2-F, 2-CF3,3-F, 3-CI, 3-Br, 3-CF3,2-CH3,4-CI, 4-Br, 4-F, 4-CF3,5-CI, 5-Br, 5-F or 5-CF3; R2 is hydrogen; Rn is 4-chloro,2,4-dichloro, 4-fluoro, 2,4-difluoro, 4-bromo, 4-methyl, 4-CF3 or4-OCF3; A is one of the molecularfragments 15 15"A A-C-OCH3 -C-OC2H5I I oooo' ' ' 'II IIOCH3 OC2H5 l_l i_i_c c alkyl ,20 1 3 20-c- -c- -c- -c-A /\ /\ /\00 00 ooooII II I I I I25 CH2OCH3 ■ CH3 • \/ • \/\ ■ 25e • .CH3-C- -C- -C-/\ /\ /\30 00 0 0 0 0 30II II IIA/\ ' \/ or \/ ;and ch3 • ch,/\35 ch3 ch3 ch3 35R4 is hydrogen, methyl, phenyl or 2,4-dichlorophenyl.5. A compound of the formula II according to claim 4, wherein R1 is 2-H, 2-F, 2-CI, 2-Br or2-CH3; R2is hydrogen; Rn in a parapositioned phenyl group is 4-chloro, 2,4-dichloro, 4-fluoro, 2,4-difluoro, 4-bromo, 40 4-methyl, 4-CF3or4-OCF3; A is one of the molecularfragments 40I 1 "A ?c\—C—OCHs —C—OC2H5 / \ / \I ' 1 'II II45 OCH3 OC2H5 •—• , •—•-Cj-C3alkyl , 45-c- -c- -c- -c-/\ /\ /\ /\ 00 00 ooooII I I I I I I50 •—•-ch.och, , ch,-«—•-ch- , 502 3 3 3 \/ \/\• • ch3-c-/X 5555 0 0 0 0 0 0 55-c-/\-c-/\0 01 10 01 I1 1 • •1 1 or • •\/\/IAch3ch3 ch.A/\ ■ • •>3 • C60 ch- ch ch-R4 is hydrogen.15GB 2 168 053 A156. A process for the preparation of a compound of the formula II as defined in claim 1, which comprises epoxidation of the corresponding styrene derivative of formula VI5 YX*2 5M ^ ii (VI), • • - o-4- -H c=ch,x ' \; 1rn.=. \/ a10 R4 10wherein R1( R2, Rn, R4 and A are as defined in claim 1.7. A process for the preparation of a compound of the formula II as defined in claim 1 wherein the molecular fragment A is the group15 15-C-OR7| /ORe20 20which comprises reacting a ketone of the formula IX25// \ • •x /r •=•n r, • r„>yx2or\// c\7,(IX)25or,30 wherein R! , R2, Rn, R4- ^6 and R7 are as defined in claim 1, with dimethylsulphonium methyl imide or dimethyloxosulfonium methyl imide.8. An oxirane compound of the formula II defined in claim 1 substantially as hereinbefore described with reference to any one of the foregoing Examples.30Printed in the UK for HMSO, D8818935, 4/86, 7102.Published by The Patent Office, 25 Southampton Buildings, London, WC2A 1AY, from which copies may be obtained.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH682282 | 1982-11-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8530463D0 GB8530463D0 (en) | 1986-01-22 |
GB2168053A true GB2168053A (en) | 1986-06-11 |
GB2168053B GB2168053B (en) | 1986-11-26 |
Family
ID=4315565
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08330970A Expired GB2130584B (en) | 1982-11-23 | 1983-11-21 | Microbicidal 1-carbonyl-1-phenoxyphenyl-2-azolylethanol derivatives |
GB08530463A Expired GB2168053B (en) | 1982-11-23 | 1985-12-11 | Phenoxy-phenyl oxirane compounds |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08330970A Expired GB2130584B (en) | 1982-11-23 | 1983-11-21 | Microbicidal 1-carbonyl-1-phenoxyphenyl-2-azolylethanol derivatives |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP0117378A1 (en) |
JP (2) | JPS59106468A (en) |
KR (1) | KR840006648A (en) |
AT (1) | ATE37180T1 (en) |
AU (3) | AU2158283A (en) |
BR (1) | BR8306422A (en) |
CA (2) | CA1215374A (en) |
DE (1) | DE3377986D1 (en) |
DK (1) | DK534083A (en) |
ES (2) | ES8504133A1 (en) |
GB (2) | GB2130584B (en) |
GR (1) | GR79723B (en) |
IL (2) | IL70284A (en) |
PH (1) | PH19709A (en) |
PL (1) | PL141026B1 (en) |
PT (1) | PT77700B (en) |
SU (1) | SU1331427A3 (en) |
TR (1) | TR21666A (en) |
ZA (2) | ZA838696B (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4517194A (en) * | 1982-06-25 | 1985-05-14 | Ciba-Geigy Corporation | Azolylmandelic acid derivatives and use thereof for controlling microorganisms |
KR880001813B1 (en) * | 1983-01-10 | 1988-09-19 | 시바-가이기 코오포레이숀 | Processes for the preparation of fluorazolyl propan derivatives |
GB8301678D0 (en) * | 1983-01-21 | 1983-02-23 | Ici Plc | Heterocyclic compounds |
EP0117578A3 (en) * | 1983-02-23 | 1985-01-30 | Shionogi & Co., Ltd. | Azole-substituted alcohol derivatives |
JPS59155365A (en) * | 1983-02-23 | 1984-09-04 | Shionogi & Co Ltd | 2-hydroxypropiophenone derivative |
US4584307A (en) * | 1983-08-10 | 1986-04-22 | Pfizer Inc. | Antifungal 2-aryl-2-hydroxy perfluoro-1-(1H-1,2,4-triazol-1-yl) alkanones and alkanols |
DE3407005A1 (en) * | 1983-09-26 | 1985-04-04 | Bayer Ag, 5090 Leverkusen | HYDROXYETHYLAZOLYL OXIME DERIVATES |
US4849007A (en) * | 1985-12-02 | 1989-07-18 | Ciba-Geigy Corporation | Herbicidal epoxides |
DE3921163A1 (en) * | 1989-06-28 | 1991-01-10 | Bayer Ag | HYDROXY KETO AZOLES |
US6297239B1 (en) | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
KR100811402B1 (en) * | 2005-06-03 | 2008-03-07 | 박명호 | shoelace ring and how to binding of shoelace |
EP2928873A1 (en) | 2012-11-27 | 2015-10-14 | Basf Se | Substituted 2-[phenoxy-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds and their use as fungicides |
WO2014082879A1 (en) | 2012-11-27 | 2014-06-05 | Basf Se | Substituted [1,2,4]triazole compounds |
US20150307459A1 (en) | 2012-11-27 | 2015-10-29 | Basf Se | Substituted 2-[phenoxy-phenyl]-1-[1,2,4]triazol-1-yl-ethanol Compounds and Their Use as Fungicides |
EP2735563A1 (en) * | 2012-11-27 | 2014-05-28 | Basf Se | Meta substituted 2-[phenoxy-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds and their use as fungicides |
WO2014082872A1 (en) * | 2012-11-27 | 2014-06-05 | Basf Se | Substituted [1,2,4]triazole compounds |
WO2014082880A1 (en) | 2012-11-27 | 2014-06-05 | Basf Se | Substituted [1,2,4] triazole compounds |
PL2934147T3 (en) | 2012-12-20 | 2020-06-29 | BASF Agro B.V. | Compositions comprising a triazole compound |
EP2943472A2 (en) * | 2013-01-08 | 2015-11-18 | Basf Se | Substituted [1,2,4]triazole compounds |
EA033780B1 (en) | 2013-01-09 | 2019-11-25 | Basf Agro Bv | Process for the preparation of substituted oxiranes and triazoles |
RU2669997C2 (en) | 2013-07-08 | 2018-10-17 | Басф Агро Б.В. | Compositions comprising triazole compound and biopesticide |
AU2015281187B2 (en) | 2014-06-25 | 2018-10-04 | BASF Agro B.V. | Pesticidal compositions |
EP3214937B1 (en) | 2014-11-07 | 2024-07-03 | Basf Se | Pesticidal mixtures |
BR112018068705B1 (en) | 2016-03-16 | 2022-09-06 | Basf Se | METHOD TO CONTROL PHYTOPATOGENIC FUNGI |
EP3429357A1 (en) | 2016-03-16 | 2019-01-23 | Basf Se | Use of tetrazolinones for combating resistant phytopathogenic fungi on cereals |
WO2017157920A1 (en) | 2016-03-16 | 2017-09-21 | Basf Se | Use of tetrazolinones for combating resistant phytopathogenic fungi on fruits |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2348663A1 (en) * | 1973-09-27 | 1975-04-03 | Bayer Ag | Alpha-phenoxy-beta-azolyl-ketones - prepd. by reacting alpha-phenoxy-beta-(methyldiethylammonio)-ketones with azoles |
CH647513A5 (en) * | 1979-11-13 | 1985-01-31 | Sandoz Ag | TRIAZOLE DERIVATIVES, THEIR PRODUCTION AND USE. |
GB2104065B (en) * | 1981-06-04 | 1985-11-06 | Ciba Geigy Ag | Heterocyclyl-substituted mandelic acid compounds and mandelonitriles and their use for combating microorganisms |
EP0078594B1 (en) * | 1981-08-19 | 1987-01-14 | Imperial Chemical Industries Plc | Triazole derivatives, processes for preparing them, compositions containing them and processes for combating fungi and regulating plant growth |
-
1983
- 1983-09-23 PH PH29875A patent/PH19709A/en unknown
- 1983-11-17 EP EP83810532A patent/EP0117378A1/en not_active Withdrawn
- 1983-11-17 AT AT83810531T patent/ATE37180T1/en active
- 1983-11-17 DE DE8383810531T patent/DE3377986D1/en not_active Expired
- 1983-11-17 EP EP83810531A patent/EP0114567B1/en not_active Expired
- 1983-11-21 IL IL70284A patent/IL70284A/en unknown
- 1983-11-21 IL IL70288A patent/IL70288A/en unknown
- 1983-11-21 GR GR73027A patent/GR79723B/el unknown
- 1983-11-21 GB GB08330970A patent/GB2130584B/en not_active Expired
- 1983-11-21 CA CA000441543A patent/CA1215374A/en not_active Expired
- 1983-11-22 PT PT77700A patent/PT77700B/en unknown
- 1983-11-22 ZA ZA838696A patent/ZA838696B/en unknown
- 1983-11-22 ES ES527438A patent/ES8504133A1/en not_active Expired
- 1983-11-22 SU SU833665903A patent/SU1331427A3/en active
- 1983-11-22 CA CA000441619A patent/CA1210404A/en not_active Expired
- 1983-11-22 TR TR21666A patent/TR21666A/en unknown
- 1983-11-22 AU AU21582/83A patent/AU2158283A/en not_active Abandoned
- 1983-11-22 ES ES527439A patent/ES8506566A1/en not_active Expired
- 1983-11-22 BR BR8306422A patent/BR8306422A/en unknown
- 1983-11-22 ZA ZA838695A patent/ZA838695B/en unknown
- 1983-11-22 PL PL1983244693A patent/PL141026B1/en unknown
- 1983-11-22 DK DK534083A patent/DK534083A/en not_active Application Discontinuation
- 1983-11-22 AU AU21581/83A patent/AU570653B2/en not_active Ceased
- 1983-11-23 KR KR1019830005542A patent/KR840006648A/en not_active Application Discontinuation
- 1983-11-24 JP JP58221352A patent/JPS59106468A/en active Pending
- 1983-11-24 JP JP58221351A patent/JPS59106467A/en active Pending
-
1985
- 1985-12-11 GB GB08530463A patent/GB2168053B/en not_active Expired
-
1988
- 1988-01-21 AU AU10692/88A patent/AU584000B2/en not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2168053A (en) | Phenexy-phenyl oxirane compounds | |
GB2166729A (en) | Fluorine containing oxirane compounds | |
NZ219282A (en) | Glycol monoethers | |
JPH0468310B2 (en) | ||
EP0032063B1 (en) | Novel substituted arylene compounds and processes for their production | |
US4377711A (en) | Novel aromatic bromopolyfluoroalkyl ethers and method for the preparation thereof | |
HU194189B (en) | Process for production of triasolile- methil-ketons | |
JP3781464B2 (en) | Process for producing arylpyrrole insecticides via oxazole intermediates | |
EP0260773A2 (en) | Process for the preparation of fluoroalkyl perfluorovinyl ethers | |
EP0375670B1 (en) | Process for preparing 3-polyfluoroalkylisoxazolylamines | |
HUT75179A (en) | Process for the preparation of 2-(methoxy-imino)-2-aryl-acetic ester derivatives via palladium-catalyzed cross coupling reaction, boron acides intermediates thereof and use of the latter | |
SU563120A3 (en) | Method for preparing 1-phenoxy-3-aminopropan-2-ol derivatives or their salts | |
US4626594A (en) | Process for the preparation of beta-hydroxyethyl-(1,2,4-triazole) derivatives | |
US4686291A (en) | Preparation of methyl ketones | |
US5434303A (en) | Process for the preparation of 1-fluoro-cyclopropane-1-carboxylic acid | |
US4992577A (en) | Preparation of 3-vinyl-substituted 2,2-dimethylcyclopropane-1-carboxylic acids and esters and intermediates therefor | |
US4751312A (en) | Process and intermediates for the synthesis of diastereomeric compounds | |
US7148384B2 (en) | Preparation of fluorinated acetophenones | |
US5723685A (en) | Preparation of monovinyl ethers | |
JPH0153262B2 (en) | ||
US4883882A (en) | Process for the preparation of compounds containing a triazole and tetrahydrofuran group, and new compounds capable of being employed for the preparation of the said compounds | |
HU192144B (en) | Process for preparing 2,2-dimethyl-3-aryl-cyclopropane-carboxylic acid derivatives | |
US4950796A (en) | Novel benzaldehydes | |
JP2001278875A (en) | Method for producing 3-fluoroalkoxymethyl-3- alkyloxetane | |
US5360935A (en) | Process for the preparation of 3-phenyl-2-propenones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |